For a complete list of publications, see Julie Overbaugh’s NCBI bibliography.
Shipley MM, Prasad VM, Doepker LE, Dingens A, Ralph D, Harkins E, Dhar A, Arenz D, Chohan V, Weight H, Mandaliya K, Bloom JD, Matsen FA, Lee KK, Overbaugh J. Functional development of a V3-specific broadly neutralizing antibody isolated from a case of HIV-1 superinfection. eLife, in press 2021.
Stoddard CI, Galloway J, Chu H, Itell HL, Shipley MM, Wolf C, Logue J, Magedson A, Sung K, Garrett M, Matsen FA, Overbaugh J. Viral proteome-wide epitope profiling reveals binding signatures of SARS-CoV-2 immune response and cross-reactivity with endemic human coronaviruses. Cell Reports, in press, 2021.
Yaffe Z, Naimen NE, Slyker J, Wines BD, Richardson BA, Bosire R, Farquhar C, Ngacha M, Nduati R, John-Stewart G, Overbaugh J. Improved HIV-infected infant survival is correlated with high levels of HIV-specific ADCC activity in multiple cohorts. Cell Reports Medicine, in press 2021.
Dingens A, Pratap P, Malone K, Hilton SK, Ketas T, Cottrell CA, Overbaugh J, Moore Simonich C, Shipley MM, Doepker L, Gobillot T, Garrett ME, Cale EM, Hennessy B, Itell H, Chohan V, Doria-Rose N, Nduati R, Overbaugh J. A diverse collection of B cells responded to HIV infection in infant BG505. Cell Rep Med. 2021;2(6):100314.
Doepker LE, Danon S, Harkins E, Ralph D, Yaffe Z, Dhar Amrit, Wagner C, Stumpf M, Arenz A, Williams JA, Lee KK, Matsen FA, Overbaugh J. Development of antibody-dependent cell cytotoxicity function in HIV-1 antibodies. Elife. 2021 Jan 11;10:e63444.
Humes D, Rainwater, S, Overbaugh J. TOP vector: a new high-titer lentiviral construct for delivery of sgRNAs and transgenes to primary T-cells. Molecular Therapy: Methods and Clinical Development Mol Ther Methods Clin Dev. 2020 Oct 27;20:30-38.
Garrett ME, Itell HL, Crawford K, Basom R, Bloom JD, Overbaugh J. Phage-DMS: a comprehensive method for fine mapping of antibody epitopes. iScience. 2020 Sep 29;23(10):101622.
Gobillot T, Humes D, Sharma A, Kikawa C, Overbaugh J. The robust restriction of Zika virus by type-I Interferon in A549 cells varies by viral lineage and is not determined by IFITM3. Viruses. 2020 May; 12(5):503.
Naiman NE, Slyker J, Nduati R, Overbaugh J. Maternal Envelope gp41 Ectodomain-Specific Antibodies Are Associated With Increased Mother-to-Child Transmission of Human Immunodeficiency Virus-1. J Infect Dis. 2020 Jan 2;221(2):232-237.
Pankau MD, Reeves DB, Harkins E, Ronen K, Jaoko W, Mandaliya K, Graham SM, McClelland RS, Matsen FA, Schiffer JT, Overbuagh J, Lehman DA. Dynamics of HIV DNA reservoir seeding in a cohort of superinfected Kenyan women. PLoS Pathog. 2020 Feb; 16(2): e1008286.
Naiman NE, Slyker J, Richardson BA, John-Stewart G, Nduati R, Overbaugh J. Antibody-dependent cellular cytotoxicity targeting CD4-inducible epitopes predicts mortality in mother-to-child transmission of HIV-1. EBioMedicine. 2019 Sep;47:257-268.
Doepker L, Simonich C, Duncan R, Gobillot T, Garrett M, Vigdorovich V, Sather DN, Nduati R, Matsen FA, Overbaugh J. Diversity and function of maternal HIV-1-specific antibodies at time of vertical transmission. J Virol. Feb 19 2020. Pii: JVI.01594-19. Epub ahead of print. PMID 32075936.
Sharma A, McLaughlin RN, Basom RS, OhAinle M, Kikawa C, Yount JS, Emerman M, Overbugh J. Macaque IFITMs limit replication of SHIVs derived from circulating HIV-1 in an Envelope-dependent manner. PLoS Pathogens. 2019 Jul; 15(7): e1007925. doi: 10.1371/journal.ppat.1007925.
Gobillot T, Kikawa C, Lehman D, Kinuthia J, Drake A, Jaoko W, Mandaliya K, John-Stewart G, McClelland RS, Overbaugh J. Zika virus circulates at low levels in Western and Coastal Kenya. J Infect Dis. 2020 Apr 3. pii: jiaa158. doi: 10.1093/infdis/jiaa158. Epub ahead of print.
Simonich CA,, Doepker LN, Ralph D, Williams JA, Dhar A, Yaffe Z, Gentles L, Small CT, Oliver B, Vigdorovich V, Prasad VM, Nduati R, Sather DN, Lee KK, Matsen FA, Overbaugh J. Rapid development of an infant-derived HIV-1 broadly neutralizing antibody lineage. Nature Communication, 10: article 2190, 2019.
Williams KL, Stumpf M, Naiman N, Ding S, Garrett M, Gobillot T, Vezina D, Dusenbury K, Ramadoss NS, Basom R, Kim PS, Finzi A, Overbaugh J. Identification of HIV gp41-specific antibodies that mediate killing of infected cells. PLoS Pathog. 2019 Feb 19;15(2):e1007572.
Dingens AS, Arenz D, Weight H, Overbaugh J, Bloom JD. An antigenic atlas of HIV-1 escape from broadly neutralizing antibodies. Immunity. 2019 Feb 19;50(2):520-532.e3.
Ohainle M, Pendergast L, Vermeire J, Roesch F, Humes D, Basom R, Delrow J, Overbaugh J, Emerman M. A Virus-Packageable CRISPR Screen Identities Host Factors Mediating Interferon Inhibition of HIV. eLife, 7:e39823, 2018.
McClelland RS, Lingappa JR, Srinivasan S, Kinuthia J, John-Stewart GC, Jaoko W, Richardson BA, Yuhas K, Fiedler TL, Mandaliya KN, Munch MM, Mugo NR, Cohen CR, Baeten JM, Celum C, Overbaugh J, Fredricks DN. Evaluation of the association between the concentrations of key vaginal bacteria and the increased risk of HIV acquisition in African women from five cohorts: a nested case-control study. Lancet Infect Dis, 18(5):554-564, 2018.
Williams KL, Wang B, Arenz D, Williams JA, Dingens AS, Cortez V, Simonich CA, Lehman DA, Rainwater S, Lee KK, Overbaugh J. Superinfection drives HIV neutralizing antibody responses from several B cell lineages that contribute to a polyclonal response. Cell Reports, 23(3):682-691, 2018.
Dingens AS, Haddox HK, Overbaugh J, Bloom JD. Comprehensive Mapping of HIV-1 Escape from Broadly Neutralizing Antibody. Cell Host & Microbe, 21(6): 777-787, 2017.
Ronen K, Dingens AS, Graham SM, Jaoko W, Mandaliya K, McClelland RS, Overbaugh J. Comprehensive Characterization of Humoral Correlates of Human Immunodeficiency Virus 1 Superinfection Acquisition in High-Risk Kenyan Women. EBioMedicine, 18, 216-244, 2017.
Boyd DF, Sharma A, Humes D, Cheng-Mayer C and Overbaugh J. Adapting SHIVs in vivo selects for Envelope-mediated Interferon- resistance. PLos Pathogens 12(7): e1005727, 2016.
Simonich CA, Williams KL, Verkerke HP, Williams JA, Nduati R, Lee KK and Overbaugh J. HIV-1 neutralizing antibodies with limited hypermuation from an infant. Cell, 166:77-87, 2016.
Milligan C, Omenda MM, Chohan V, Odem-Davis K, Richardson BA, Nduati R and Overbaugh J. Maternal neutralization-resistant virus variants do not predict infant HIV infection risk. mBio 7, 2016.
McClelland RS, Richardson BA, Cherutich P, Mandaliya K, John-Stewart G, Miregwa B, Odem-Davis K, Jaoko W, Kimanga D and Overbaugh J. A 15-year study of the impact of community antiretroviral therapy coverage on HIV incidence in Kenyan female sex workers: A fifteen-year prospective study. AIDS, 29: 2279-2286, 2015. AIDS Res Hum Retroviruses. 2015 Mar;31(3):288-92.
Williams KL, Cortez V, Dingens AS, Gach JS, Rainwater S, Weis JF, Chen X, Spearman P, Forthal DN and Overbaugh J. HIV-specific CD4-induced antibodies mediate broad and potent antibody-dependent cellular cytotoxicity activity and are commonly detected in plasma from HIV-infected humans. EBioMedicine 2, 1464-1477, 2015.
Cortez V, Wang B, Dingens A, Chen MM, Ronen K, Georgiev IS, McClelland RS, Overbaugh J. The broad neutralizing antibody responses after HIV-1 superinfection are not dominated by antibodies directed to epitopes common in single infection. PLoS Pathogens, 11(7): e1004973, 2015.
Myerson NR, Sharma A, Wilkerson GK, Overbaugh J, Sawyer SL. Identification of a nonhuman primate CD4 receptor broadly compatible with primary HIV-1 isolates. J. Virol. 89:8611-8622, 2015.
Milligan C, Richardson BA, John-Stewart G, Nduati R, Overbaugh J. Passively acquired antibody–dependent cellular cytotoxicity (ADCC) activity in HIV-infected infants is associated with reduced mortality. Cell Host& Microbe 17: 500-506, 2015.
Boyd DF, Peterson D, Haggarty BS, Jordan APO, Hogan MJ, Goo L, Hoxie JA, Overbaugh J. Mutations in HIV-1 envelope that enhance entry with the macaque CD4 receptor alter antibody recognition by disrupting quaternary interactions within the trimer. Journal of Virology. 15;89(2):894-907, 2015.
Ronen K, Richardson BA, Graham SM, Jaoko W, Mandaliya K, McClelland RS, Richardson BA, Overbaugh J. HIV-1 superinfection is associated with an accelerated viral load increase but has a limited impact on disease progression. AIDS 28:2281-2286, 2014.
Goo L, Chohan V, Nduati R, Overbaugh J. Early development of broad neutralizing antibodies in HIV-1 infected infants. Nat Med., 20, 655-658, 2014.
Overbaugh J. Understanding protection from SARS-CoV-2 reinfection. Nature Med, 26, 1680-1681. Nat Med. 2020 Nov;26(11):1680-1681
Clynes M, Corbett A, Overbaugh J. Why we need good mentoring. Nature Reviews Cancer, in press, 2019.
Overbaugh J. Defining the barriers to women publishing in high-impact journals. J Virol, 92(7), 2018.
Overbaugh J. Gender Bias: track revisions and appeals. Nature: 543: 40, 2017.
Ronen K, Sharma A, Overbaugh J. HIV transmission biology: translation for HIV prevention. AIDS 29: 2219-2227, 2015
Overbaugh, J. Mother-Infant HIV Transmission: Do maternal HIV-specific antibodies protect the infant? PLoS Pathogens 10:e1004283, 2014.
Overbaugh J. 24/7 isn’t the only way: A healthy work-life balance can enhance research. Nature 477(7362): 27-28, 2011.